Company profile
Home | Panakeia
Panakeia Technologies Limited is a UK company with status active founded in 2018 based in East of England.
Financial period: 1 Dec 2023 to 30 Nov 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
SH01 | Transaction MzUyMzI4NzIwOGFkaXF6a2N4
Published 22 May 2026 14:35
RP01CS01 | Transaction MzUyMjgxMjM0NWFkaXF6a2N4
Published 22 May 2026 14:14
CS01 | Transaction MzUwOTAyNzkzMWFkaXF6a2N4 | Paper/PDF filed
Published 19 Jun 2026 22:39
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQzNDA4NjQ1MmFkaXF6a2N4
Published 31 Aug 2024 21:28
CS01 | Transaction MzQwNTM4NTgwNGFkaXF6a2N4 | Paper/PDF filed
Published 22 May 2026 22:59
Company registered at Companies House
1 Sep 2025 to 31 Aug 2026
This project involves multi-site evaluation of Panakeia's innovative AI software that could revolutionise colorectal cancer diagnosis. With rising cancer rates and an overstretched pathology workforce, the NHS urgently needs faster, more cost-effective diagnostic solutions. This AI technology, developed by UK company Panakeia, analyses routine colorectal ...
1 Aug 2024 to 31 Jan 2026
This project focuses on real-world testing of an AI-tool which informs the diagnosis and treatment of breast cancers in minutes, without the need for wet lab based tests. Currently, treatment decision-making for cancers requires several molecular tests subsequent to the confirmatory diagnosis of cancer by a pathologist. With increasing breast cancer incid...
1 May 2023 to 31 Oct 2024
_This project aims to improve accuracy, reduce costs and turnaround times for the diagnosis of colon cancer. Currently, cancer diagnoses require several screening molecular tests subsequent to the confirmatory diagnosis of cancer by a pathologist._ _With increasing colon cancer incidence and an ageing workforce (60.7% of pathologists being \>55 years of a...
